Details for New Drug Application (NDA): 218725
The generic ingredient in SOLRIAMFETOL HYDROCHLORIDE is solriamfetol hydrochloride. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the solriamfetol hydrochloride profile page.
Summary for 218725
| Tradename: | SOLRIAMFETOL HYDROCHLORIDE |
| Applicant: | Aurobindo Pharma Ltd |
| Ingredient: | solriamfetol hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 75MG BASE | ||||
| Approval Date: | Oct 6, 2026 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 150MG BASE | ||||
| Approval Date: | Oct 6, 2026 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
